News
Tramway Venture Partners
How The BioScience Center is helping New Mexico’s tech industry thrive
Technology continues to advance extremely quickly across the globe, and that is no different here in New Mexico. Some of the major growth that the Land of Enchantment is seeing…
Tramway Ventures lands state boost for new $40M fund
By Jacob Maranda – New Mexico Inno Reporter September 19, 2023, 05:12pm MDT There could soon be a lot more venture capital flowing into New Mexico companies thanks to…
Tramway Ventures Welcomes Chris Japp as Managing Partner
[Albuquerque, August 21, 2023] – Tramway Ventures, New Mexico’s leading life sciences and healthcare venture capital firm, proudly announces the appointment of Chris Japp as Managing Partner to the firm….
Armonica Technologies
Armonica Technologies secures new patents advancing their long-read DNA successes
ALBUQUERQUE, N.M., Nov. 14, 2018 /PRNewswire/ — Armonica Technologies, Inc, an Albuquerque, NM-based company focused on building its proprietary long-read DNA sequencing technology (the “Company”), chalked up new Intellectual Property success in…
University of New Mexico Spinout Aims to Develop Nanopore Sequencing Technology
SAN FRANCISCO (GenomeWeb) – Armonica Technologies, a startup that has spun out of the University of New Mexico, is looking to develop nanopore sequencing technology that relies on stretching DNA…
STC.UNM Startup Armonica Technologies, Inc. Receives Investment from State Catalyst Fund
Armonica Technologies, Inc., an STC.UNM startup commercializing new technology that promises to be a gigantic leap in genomic sequencing capabilities, has received a $1.5 million investment from the state’s Catalyst…
- « Previous
- 1
- 2
- 3
- 4
- Next »
BennuBio
BennuBio acquired by California firm
The Albuquerque company, founded in 2018, will maintain a presence in the city Albuquerque Journal |12 Oct 2025 |BY NATALIE ROBBINS JOURNAL STAFF WRITER Natalie Robbins covers the economy and…
Precision Cell Systems Acquires BennuBio to Enter the 3D Cell Culture Market
LIVERMORE, Calif., Oct. 1, 2025 /PRNewswire/ — Precision Cell Systems (PCS) today announced the acquisition of BennuBio, marking a significant entry into the rapidly growing 3D cell culture market. According…
BennuBio Receives SLAS 2022 Ignite Award
February 27, 2022 BennuBio announced it received the Society for Laboratory Automation and Screening (SLAS) prestigious Ignite award at SLAS’s annual International Conference and Exhibition in Boston, MA on February…
Circular Genomics
Circular Genomics Strengthens Scientific Advisory Board with the Addition of Esteemed Alzheimer’s Experts
Michael Weiner, MD and Timothy Hohman, PhD, bring decades of experience in neurological diseases with a focus on Alzheimer’s disease SAN DIEGO, Dec. 8, 2025 /PRNewswire/ — Circular Genomics, a…
Circular Genomics Announces Closure of $15 Million Series A Financing to Advance First-in-Class Circular RNA Platform for Early Detection of Alzheimer’s Disease
SAN DIEGO, Dec. 1, 2025 /PRNewswire/ — Circular Genomics, Inc., the world-leading developer of circular RNA-based precision medicine tools for neurology and psychiatry, today announced the successful closure of a $15…
Circular Genomics to Unveil New Data Highlighting Circular RNAs as a Transformative New Class of Blood-Based Biomarkers for Alzheimer’s Disease at CTAD 2025
New clinical data highlights circular RNAs (circRNAs) as a novel, non-invasive blood biomarker platform for the early detection of Alzheimer’s Disease (AD). The research demonstrates that circRNAs offer comprehensive insights into…
WaveDyn Vision
Senior Ophthalmology Executive Thomas A. (Tom) Dunlap Joins WaveFront Dynamics Inc. as an Independent Member of the Board of Directors to Support the Company’s Ongoing Commercialization and Broader Strategic Initiatives
ALBUQUERQUE, N.M.–(BUSINESS WIRE)–WaveFront Dynamics Inc. (WDI), a venture backed company and pioneer in wavefront sensing technology for use in measuring and perfecting visual performance, today announced the appointment of Tom…
WaveFront Dynamics Inc. Launches WaveDȳn® Vision Analyzer
ALBUQUERQUE, N.M.–(BUSINESS WIRE)–WaveFront Dynamics Inc., an ophthalmic medical device company, announced today the commercial launch of its dynamic aberrometry measurement system, the WaveDyn Vision Analyzer. The WaveDyn Vision Analyzer (pronounced…
WaveFront Dynamics Inc. Initiates $3mm Series A Round to Fund Continued Development of Dynamic Wavefront Measurement System for Vision Correction
ALBUQUERQUE, N.M.–(BUSINESS WIRE)–WaveFront Dynamics Inc. (WaveDyn™), an early stage ophthalmic medical device company, today announced the first close of a $3 million Series A financing round. The round was led by…
Vitazi.ai
VSP Vision Innovation Challenge Winners Revealed at Vision Expo West 2025
LAS VEGAS—Vision Expo West, produced by RX and The Vision Council, in collaboration with VSP Vision, a leader in health-focused vision care, and MATTER, the premier health care incubator and…
Vitazi.ai Announces Partnership with Eye Associates of New Mexico to Advance AI-Powered Retinal Screening
SANTA FE, N.M., Feb. 12, 2025 /PRNewswire/ — Vitazi.ai, Inc., a key leader in Oculomics, is pleased to announce an agreement with Eye Associates of New Mexico, the largest ophthalmology…
Vitazi.ai Creates a Platform to Deliver Artificial Intelligence to Improve Physician Efficiency and Diagnostics Accuracy
Vitazi.ai is reimagining image-based diagnostics so providers can gain higher quality, real time & trustable health insights. October 8, 2021 Albuquerque, New Mexico — Today Tramway Venture Partners…